UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.169

Sortiert nach

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

Leukemia, 2016-11, Vol.30 (11), p.2208-2213

2016

Volltextzugriff (PDF)

Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis

Bone marrow transplantation (Basingstoke), 2013-04, Vol.48 (4), p.557-561

2013

Volltextzugriff (PDF)

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

Leukemia, 2007-09, Vol.21 (9), p.2035-2042

2007

Volltextzugriff (PDF)

Pomalidomide (CC4047) plus low dose dexamethasone (Pom dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)

Leukemia, 2010-11, Vol.24 (11), p.1934-1939

2010

Volltextzugriff (PDF)

Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma

Leukemia, 2016-03, Vol.30 (3), p.633-639

2016

Volltextzugriff (PDF)

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma

Blood cancer journal (New York), 2017-09, Vol.7 (9), p.e600-e600

2017

Volltextzugriff (PDF)

Second auto-SCT for treatment of relapsed multiple myeloma

Bone marrow transplantation (Basingstoke), 2013-04, Vol.48 (4), p.568-573

2013

Volltextzugriff (PDF)

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

Leukemia, 2007-03, Vol.21 (3), p.529-534

2007

Volltextzugriff (PDF)

Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival

Bone marrow transplantation (Basingstoke), 2017-08, Vol.52 (8), p.1126-1132

2017

Volltextzugriff (PDF)

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

Bone marrow transplantation (Basingstoke), 2009-04, Vol.43 (8), p.619-625

2009

Volltextzugriff (PDF)

Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center

Bone marrow transplantation (Basingstoke), 2013-10, Vol.48 (10), p.1302-1307

2013

Volltextzugriff (PDF)

Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial

Leukemia, 2018-03, Vol.32 (3), p.719-728

2018

Volltextzugriff (PDF)

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

Leukemia, 2013-01, Vol.27 (1), p.220-225

2013

Volltextzugriff (PDF)

Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis

Journal of internal medicine, 2017-06, Vol.281 (6), p.611-619

2017

Volltextzugriff (PDF)

Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.970-975

2011

Volltextzugriff (PDF)

Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (12), p.1543-1547

2013

Volltextzugriff (PDF)

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

Leukemia, 2014-05, Vol.28 (5), p.1122-1128

2014

Volltextzugriff (PDF)

Impact of early relapse after auto-SCT for multiple myeloma

Bone marrow transplantation (Basingstoke), 2008-09, Vol.42 (6), p.413-420

2008

Volltextzugriff (PDF)

Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma

Leukemia, 2013-10, Vol.27 (10), p.2062-2066

2013

Volltextzugriff (PDF)

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.201-205

2014

Volltextzugriff (PDF)

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

Bone marrow transplantation (Basingstoke), 2006-06, Vol.37 (11), p.1003-1008

2006

Volltextzugriff (PDF)

Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis

Neurology, 2010-03, Vol.74 (11), p.913

2010

Volltextzugriff (PDF)

Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category

Leukemia, 2017-07, Vol.31 (7), p.1562-1569

2017

Volltextzugriff (PDF)

Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma

Bone marrow transplantation (Basingstoke), 2007-05, Vol.39 (10), p.605-611

2007

Volltextzugriff (PDF)

SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.956-961

2011

Volltextzugriff (PDF)

1 – 25 von 2.169

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.955)
Mit Volltextzugriff
(1.907)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(1.267)
MEDLINE
(938)
Journals@Ovid Ovid Full Text 学内アクセス
(758)
Ingenta
(753)
Publisher website
(691)
IngentaConnect Journals
(376)
Elsevier ScienceDirect Journals Complete
(376)
Wiley Online Library
(312)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(312)
Wiley Online Library Full Collection 2018
(214)
Nature_系列刊
(156)
Nexis Uni
(116)
SpringerLink (Online service)
(110)
JSTOR
(79)
Taylor & Francis Online
(67)
Oxford Journals
(67)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(66)
Taylor & Francis
(63)
Taylor & Francis Journals
(47)
SAGE Journals
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(296)
Journal Of Clinical Oncology
(102)
International Journal Of Radiation Oncology, Biology, Physics
(66)
Physics Letters. B
(60)
American Journal Of Hematology
(57)
Leukemia
(47)
Mayo Clinic Proceedings
(41)
Blood Cancer Journal
(35)
Bone Marrow Transplantation
(34)
Circulation
(23)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

Pomalidomide (CC4047) plus low dose dexamethasone (Pom dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)

Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma

Second auto-SCT for treatment of relapsed multiple myeloma

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center

Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis

Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006

Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

Impact of early relapse after auto-SCT for multiple myeloma

Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis

Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category

Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma

SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization

Suchergebnisse filtern